文献速递外周动脉疾病

髂总动脉支架再干预预测因素:支架直径而非性别

Stent Diameter, Not Sex, Is Predictive of Reintervention after Common Iliac Artery Stenting.
PubMed 文献 · Ann Vasc Surg · 2026-03-28

基于VQI数据库2015-2022年4844例因PAD行单侧择期髂总动脉支架的患者,女性占40.0%。女性支架直径更小(38.0% vs 17.8%),但性别与再干预无关;小支架(<8 mm)与再干预增加相关(P<0.001),且性别间无交互作用。

要点

  • 小支架直径(<8 mm)与髂总动脉支架术后1年再干预风险增加相关
  • 女性性别本身并非再干预的独立预测因素
  • 女性更少接受最佳药物治疗且更常置入小支架,可能解释长期预后差异

核心结论

  • 小支架直径而非女性性别与髂总动脉支架术后再干预风险增加相关。

研究设计与样本

  • 回顾性队列研究,纳入Vascular Quality Initiative外周血管干预数据库2015-2022年4844例因PAD行单侧择期髂总动脉支架的成人患者,排除动脉瘤及缺乏随访者。

主要发现

  • 女性占40.0%,年龄更大(67.8±10.7 vs 67.1±9.7岁),合并症更少,围术期阿司匹林(72.9% vs 76.2%)和他汀(75.8% vs 79.6%)使用率更低(均P<0.05)。
  • 女性更常表现为慢性肢体威胁性缺血(39.5% vs 32.7%,P<0.001),且更常接受小支架(38.0% vs 17.8%,P<0.001)。
  • 小支架与再干预增加相关(P<0.001),性别与再干预无关,小支架与再干预的关联在性别间无差异(交互作用P>0.05)。

关键数值与推荐

  • 小支架定义为直径<8 mm。
  • 多数支架用于间歇性跛行(64.4%)。

临床怎么用

  • 髂总动脉支架选择时应优先考虑足够大的支架直径以降低再干预风险。
  • 女性患者应加强围术期最佳药物治疗(阿司匹林、他汀),并避免不必要的小支架置入。

局限性

  • 原文未报告

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Female sex is associated with adverse limb events following revascularization for peripheral artery disease (PAD). Specifically, poorer patency, with more reinterventions following iliac artery stenting. We hypothesize stent diameter will be associated with an increased risk of reintervention among all patients regardless of sex group. METHODS: We included adults undergoing unilateral, elective, index, common iliac stenting only for PAD (Vascular Quality Initiative peripheral vascular interventions database; 2015-2022) excluding those with aneurysms and lacking follow-up. Stents <8 mm were defined as small. Kaplan-Meier and multivariable Cox regression compared 1-year reintervention. Interaction terms evaluated subgroups. RESULTS: We identified 4,844 patients including 1,935 (40.0%) females. Females were older (67.8 ± 10.7 vs. 67.1 ± 9.7) with fewer comorbidities and were less frequently prescribed perioperative aspirin (72.9% vs. 76.2%) or statins (75.8% vs. 79.6%, all P < 0.05). Most stents were for claudication (64.4%), yet females had more critical limb threatening ischemia (39.5% vs. 32.7%; P < 0.001). Although females received smaller stents (38.0% vs. 17.8%, P < 0.001), sex was not associated with reintervention. Smaller stents were associated with increased reintervention (P < 0.001). The association between small stents and increased reinterventions did not differ between sexes (p-interaction>0.05). CONCLUSION: Small stent diameter, not female sex, was associated with an increased risk of reintervention following iliac stents for PAD. However, females were less frequently medically optimized and received smaller stents, possibly contributing to long-term stent failure described previously.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Lowenkamp MN, Reitz KM, Sridharan N, et al. Stent Diameter, Not Sex, Is Predictive of Reintervention after Common Iliac Artery Stenting. Ann Vasc Surg. 2026. PMID: 41912028. doi:10.1016/j.avsg.2026.03.035

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。